| abstract |
There is provided a compound having Formula I or a pharmaceutically acceptable salt, hydrate or N-oxide thereof, useful for treating a disease that binds to CXCR7 and partially or wholly depends on CXCR7 activity: Accordingly, the present invention further provides a composition containing one or more of the aforementioned compounds, in admixture with a pharmaceutically acceptable excipient. |